Literature DB >> 23190288

Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review.

H M B Lunde1, B Bjorvatn, K-M Myhr, L Bø.   

Abstract

The major sleep disorders are common in multiple sclerosis (MS) and are associated with significant morbidity. Despite this, the rate of recognition and management of these conditions are low. All types of sleep disorders are seen in patients with MS: insomnia, circadian rhythm sleep disorders, sleep-related movement disorders, sleep-related breathing disorders, hypersomnia (narcolepsy), and parasomnia (REM sleep behavior disorder; RBD). This literature review covers the prevalence, clinical features, and treatment of sleep disorders in MS. Based on clinical experience, the spectrum of symptoms associated with MS, and the current knowledge of MS pathophysiology, we have also enclosed proposed strategies for clinical assessment and investigation of sleep disorders in MS patients.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2013        PMID: 23190288     DOI: 10.1111/ane.12046

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


  12 in total

1.  Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls.

Authors:  Philip Brenner; Ellenor Mittendorfer-Rutz; Jussi Jokinen; Kristina Alexanderson; Jan Hillert; Petter Tinghög
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-05-11       Impact factor: 4.328

2.  Sleep and oligodendrocyte functions.

Authors:  Michele Bellesi
Journal:  Curr Sleep Med Rep       Date:  2015-03-01

3.  Case Report: Rapid Eye Movement Sleep Behavior Disorder as the First Manifestation of Multiple Sclerosis: A Case Report and Literature Review.

Authors:  Alejandro Enriquez-Marulanda; Valentina Quintana-Peña; Yuri Takeuchi; Jairo Quiñones
Journal:  Int J MS Care       Date:  2018 Jul-Aug

Review 4.  Potential Circadian Rhythms in Oligodendrocytes? Working Together Through Time.

Authors:  Christopher S Colwell; Cristina A Ghiani
Journal:  Neurochem Res       Date:  2019-03-25       Impact factor: 3.996

Review 5.  Sleep Abnormalities in Multiple Sclerosis.

Authors:  Giorgos K Sakkas; Christoforos D Giannaki; Christina Karatzaferi; Mauro Manconi
Journal:  Curr Treat Options Neurol       Date:  2019-01-31       Impact factor: 3.598

6.  Fatigue in multiple sclerosis: a look at the role of poor sleep.

Authors:  Lauren B Strober
Journal:  Front Neurol       Date:  2015-02-12       Impact factor: 4.003

Review 7.  Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Int J Mol Sci       Date:  2018-04-16       Impact factor: 5.923

Review 8.  Sleep loss as a factor to induce cellular and molecular inflammatory variations.

Authors:  Gabriela Hurtado-Alvarado; Lenin Pavón; Stephanie Ariadne Castillo-García; María Eugenia Hernández; Emilio Domínguez-Salazar; Javier Velázquez-Moctezuma; Beatriz Gómez-González
Journal:  Clin Dev Immunol       Date:  2013-12-03

9.  Sleep, plasticity and the pathophysiology of neurodevelopmental disorders: the potential roles of protein synthesis and other cellular processes.

Authors:  Dante Picchioni; R Michelle Reith; Jeffrey L Nadel; Carolyn B Smith
Journal:  Brain Sci       Date:  2014-03-01

10.  Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study.

Authors:  Philip Brenner; Kristina Alexanderson; Charlotte Björkenstam; Jan Hillert; Jussi Jokinen; Ellenor Mittendorfer-Rutz; Petter Tinghög
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.